Evidence for an overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitis

Journal of Hepatology

Volumn 24, Issue 6, 1996, Pages 699-705

  Gohlke, Frank ^a   Lohse, Ansgar W ^a   Dienes, Hans P ^a   Löhr, Hanns ^a   Märker Hermann, Elisabeth ^a   Gerken, Guido ^a   Meyer zum Büschenfelde, Karl Hermann ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Autoimmune hepatitis; Immunosuppressive therapy; Overlap syndrome; Primary sclerosing cholangitis; Ursodeoxycholic acid

Indexed keywords

AZATHIOPRINE; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE; URSODEOXYCHOLIC ACID;

ADULT; ARTICLE; AUTOIMMUNE HEPATITIS; CASE REPORT; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL;

EID: 0030175723     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(96)80266-2     Document Type: Article

References (25)

1. Meyer zum Büschenfelde K-H, Lohse AW, Manns M, Poralla T. Autoimmunity and liver disease. Hepatology. 12:1990;354-363.
2. LaRusso NF, Wiesner RH, Ludwig J, MacCarty RL. Current concepts: primary sclerosing cholangitis. N Engl J Med. 310:1984;899-903.
3. Bennett RM. Mixed connective tissue disease and other overlap syndromes. Kelly WN, Harris ED, Ruddy S, Sledge CB. 4th Edit Textbook of Rheumatology. 1993;1057-1076 W.B. Saunders Company, Philadelphia.
4. Klöppel G, Seifert G, Lindner H, Dammermann R, Sack HJ, Berg PA. Histopathological features in mixed types of chronic aggressive hepatitis and primary biliary cirrhosis. Virchows Arch Pathol Anat. 373:1977;143-160.
5. Michieletti P, Wanless IR, Katz A, Scheurer PJ, Yeaman SJ, Palmer JM, Heathcote EJ. Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis. Gut. 35:1994;260-265.
6. Brunner G, Klinge O. Ein der chronisch-destruierenden nicht-eitrigen Cholangitis ähnliches Krankheitsbild mit antinukleären Antikörpern (Immunocholangitis). Dtsch Med Wochenschr. 112:1987;1454-1458.
7. Ben-Ari Z, Dhillon AP, Sherlock S. Autoimmune cholangiopathy: part of the spectrum of autoimmune chronic active hepatitis. Hepatology. 18:1993;10-15.
8. Mayet WJ, Hess G, Gerken G, Rossol S, Voth R, Manns M, Meyer zum Büschenfelde K-H. Treatment of chronic type B hepatitis with recombinant α-interferon induces autoantibodies not specific for autoimmune chronic hepatitis. Hepatology. 10:1989;24-28.
9. Manns M, Gerken G, Kyriatsoulis A, Trautwein C, Reske K, Meyer zum Büschenfelde K-H. Two different subtypes of antimitochondrial antibodies are associated with primary biliary cirrhosis: identification and characterization by radioimmunoassay and immunoblotting. Hepatology. 7:1987;893-899.
10. Manns M, Gerken G, Kyriatsoulis A, Staritz M, Meyer zum Büschenfelde K-H. Characterizationof a new subgroup of autoimmune chronic hepatitis by autoantibodies against a soluble liver antigen. Lancet. i:1987;292-294.
11. Manns M, Meyer zum Büschenfelde K-H, Slusarczyk J, Dienes HP. Detection of liver-kidney microsomal autoantibodies by radioimmunoassay and their relation to antimitochondrial antibodies in inflammatory liver disease. Clin Exp Immunol. 57:1984;600-608.
12. Mayet W-J, Csernok E, Szymkowiak C, Gross WI, Meyer zum Büschenfelde K-H. Human endothelial cells express proteinase 3, the target antigen of anticytoplasmic antibodies in Wegener's granulocytosis. Blood. 84:1993;1221-1229.
13. Treichel U, Gerken G, Rossol S, Rotthauwe HW, Meyer zum Büschenfelde K-H, Poralla T. Autoantibodies against the human asialoglycoprotein receptor: effects of therapy in autoimmune and virus-induced chronic active hepatitis. J Hepatol. 19:1993;55-63.
14. Gordon H, Sweets JAH. A simple method for silver impregnation of reticulin. Am J Pathol. 12:1936;545-546.
15. Dienes HP, Popper H, Manns M, Baumann W, Thoenes W, Meyer zum Büschenfelde K-H. Histologic features in autoimmune hepatitis. Z Gastroenterol. 27:1989;325-330.
16. Flora K, Benner K, Lee R, Fennimore S. Primary autoimmune cholangitis as an early variant of primary biliary cirrhosis [Abstract]. Hepatology. 20:1994;152A.
17. Johnson PJ, McFarlane IG. Meeting Report: International Autoimmune Hepatitis Group. Hepatology. 18:1993;998-1005.
18. Lawrence ST, Sherman KE, Lawson JM, Goodman ZD. A 39-year-old man with chronic hepatitis. Semi Liver Dis. 14:1994;97-105.
19. Minak G, Sutherland LR, Pappas C, Kelly JK, Martin SE. Autoimmune chronic active hepatitis (lupoid hepatitis) and primary sclerosing cholangitis in two young adult females. Can J Gastroenterol. 2:1988;22-27.
20. Rabinovitz M, Demetris AJ, Bou-Abboud CF, Van Thiel DH. Simultaneous occurrence of primary sclerosing cholangitis and autoimmune chronic active hepatitis in a patient with ulcerative colitis. Dig Dis Sci. 37:1992;1606-1611.
21. El-Shabrawi M, Wilkinson ML, Portmann B, Mieli-Vergani G, Chong SKF, Williams R, Mowat AP. Primary sclerosing cholangitis in childhood. Gastroenterology. 92:1987;1226-1235.
22. Donaldson P, Doherty D, Underhill J, Williams R. The molecular genetics of autoimmune liver disease. Hepatology. 20:1994;225-239.
23. Lee Y-M, Kaplan MM. Primary sclerosing cholangitis. N Engl J Med. 332:1995;924-933.
24. Targan SR, Landers C, Vidrich A, Czaja AJ. High-titer anti-neutrophil cytoplamic antibodies in type-1 autoimmune hepatitis. Gastroenterology. 108:1995;1159-1166.
25. Stiehl A, Walker S, Stiehl L, Rudolph G, Hofmann WJ, Theilmann L. Effect of ursodeoxycholic acid on liver and bile duct disease in primary sclerosing cholangitis. A 3-year pilot study with a placebo-controlled study period. J Hepatol. 20:1994;57-64.